Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH chair re-elected for second term
Gaynor Hillier, head of Elanco Animal Health UK and Ireland was first elected chair in 2017.
Elanco head outlines proposed strategic framework 

Gaynor Hillier, head of Elanco Animal Health UK and Ireland, has been re-elected as chair of the National Office of Animal Health (NOAH).

She was first elected in 2017, having been an active member of the board since 2011 and vice-chair since 2013.

Speaking at NOAH member’s day, Gaynor outlined the proposed strategic framework for 2018-23. In the short to mid-term, Brexit will be a top priority, as NOAH works to support business continuity and opportunity.

“Our regulatory focus remains as important as ever,” she added. “As does our work on One Health topics, ensuring appropriate access and responsible use of medicines for all animals.

“We will work on delivering for our members, current and future, to provide relevant services to our current and broadening membership in the face of a changing market landscape and we will capitalise on our position as the voice of our industry to promote the benefits of our sector to society and to help create a climate where our member businesses can succeed.”

NOAH members were invited to discuss the proposals and offer feedback. The strategic framework will be finalised at the next board meeting this month.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'